Glaxo Considers Developing Gonorrhea Vaccine as Threat Rises
A scientist mixes chemicals inside the new lab at the GlaxoSmithKline Plc facility in Collegeville, Pennsylvania, U.S. (Photographer: Eric Thayer/BloombergPhotographer: Eric Thayer/Bloomberg)

Glaxo Considers Developing Gonorrhea Vaccine as Threat Rises

Bookmark
(Bloomberg) -- GlaxoSmithKline Plc is considering whether to develop a new vaccine against a sexually-transmitted infection that’s threatening to become unstoppable.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.